Pierre Gaudriault

Pierre Gaudriault is currently the Chief Business Development Officer at Cherry Biotech, where Pierre also holds the title of R&D Project Manager. Previously, Pierre was a PharmD-PhD student at IRSET/INSERM U1085, focusing on the effect of endocrine disrupting chemicals on human steroidogenesis. Pierre has also interned at various research and pharmaceutical institutions, working on projects such as new polyamine macrocycle synthesis. Pierre holds a Doctor of Pharmacy degree, a PhD in Human toxicology, and a Master of Science in Human toxicology. Additionally, Pierre completed a short course on mixture toxicology.